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Figure 2. SSCP and sequencing analysis of angiofibromas (case 3, left;
case 5, right). Both cases show aberrant bands on the SSCP gels (arrows; T,
tumor tissue; N, normal control tissue). In addition to the aberrant bands,
strong wild-type bands are present in both tumors. Sequencing analysis shows
a A→T transition at nucleotide 517 (AAG to TAG; case 3) and a transversion
of GG→AA at nucleotide 1184–5 (GAG GAG to GAA AAG; case 5), on
exons 2 and 8.
with normal somatic cells was implicated for the negative results in a
recent study that failed to detect LOH in three angiofibromas from
MEN1 patients (Dong et al, 1997).
Erythropoietic Protoporphyria: A New Mutation Responsible
for Exon Skipping in the Human Ferrochelatase Gene
To the Editor:
Erythropoietic protoporphyria is an inherited disorder associated with
intense light sensitivity caused by the diminished activity of the enzyme
ferrochelatase. It catalyzes the last step in haem biosynthesis by inserting
ferrous ion into protoporphyrin IX. A reduction in enzyme activity
of 30%–50% in different tissues is characteristic in patients and produces
an accumulation of protoporphyrin IX in erythrocytes, serum, liver,
and feces followed by lethal obstructive hepatic failure in some cases
(Todd, 1994). The ferrochelatase gene was cloned and localized to
chromosome 18q 21.3. Since then several mutations have been
published with different forms of transmission, demonstrating the
heterogeneity of the molecular pathology responsible for erythropoietic
protoporphyria. Discovering new mutations and correlating these with
the biochemical data may help in predicting the clinical course of the
disease and would allow intervention to combat any possibly lethal
consequences.
A blood sample was taken from a 35 y old man who has been
suffering from burning sensations, pain, and iching since his early
childhood, and from time to time the occurrence of small vesicles after
exposure to sun light. His parents are symptomless and there is no
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The identification of distinct somatic MEN1 mutations in sporadic
(non-MEN1 associated) angiofibroma suggests a role for the MEN1
gene product not only in MEN1 patients, but also in the initiation
and/or progression of a subset of sporadic angiofibromas.
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history of photosensitivity in other family members. Physical examina-
tion revealed orange peel-like skin on his forehead, nose, and hands
and his red blood cells showed red fluorescence under UVA illumination
due to raised protoporphyrin levels. Its concentration in erythrocyte
was 432 µg per 100 ml RBC and ferrochelatase activity in periferal
lymphocytes was decreased to 35% of normal levels (Nunn et al, 1988).
He has taken beta-carotene with slight benefical effects.
Peripheral blood samples from the probands’ father, mother, sister,
and 11 y old daughter were also collected and the lymphocytes isolated.
Total RNA and DNA were extracted from them and complementary
DNA synthetized by reverse transcriptase polymerase chain reaction
using the forward primer, p1 (59-GAGGCTGCCCAGGCAA-39;
Nakahashi et al 1993) and the reverse primer, p2 (59 -TTTTCAACT-
CCACACTCC-39). The latter was designed with the help of the
GCG computer program and allows amplification of most of the amino
acid coding region (1105 bp). After purifying the polymerase chain
reaction product, chemical cleavage of mismatch analysis was carried
out to identify the site of the deletion. Asymmetric polymerase chain
reactions were subsequently carried out and chain termination DNA
sequencing was performed to characterize the mutation. The boundaries
of exon 2 were amplified with primer sets 3 (Wang et al, 1994) using
genomic DNA as the template.
The proband’s amplified cDNA was found to be µ100 bp shorter
than that from the control (Fig 1A, II.2). Polymerase chain reactions,
using nested primers, showed that the site of the deletion was near the
59-end of the cDNA (data not shown). Direct sequencing of the
cDNA using the p1 forward primer subsequently revealed that exon
2 (127 bp) was missing (Fig 1B). The boundaries of exon 2 in the
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Figure 1. Exon 2 skipping in the human ferrochelatase cDNA. (A) Three per cent agarose gel electrophoresis of reverse transcriptase polymerase chain
reaction-amplified ferrochelatase mRNA. The proband (II2), his mother (I2), and his daughter (III1) exhibit a normal polymerase chain reaction product (1.1 kb)
and a short product, indicating the loss of µ100 bp of cDNA. (B) Ferrochelatase cDNA sequence showing the loss of exon 2 in the patient.
Figure 2. Identification of the mutation among the members of the
family. (A) Pedigree. Proband with clinical symptoms is indicated by black
shading. (B) Direct sequencing of intron 1/exon 2 boundary of ferrochelatase
gene showing the G→C tranversion at IVS1–1 in the proband II2, his daughter
III1, and his mother I2.
genomic DNA were therefore sequenced to determine whether or
not a splice mutation was responsible for the loss of exon 2. The results
showed that the mutation is indeed a G→C transversion at the acceptor
site, IVS1–1, and has not been previously reported. The same mutation,
but showing incomplete penetrance, was found in his mother and
daughter (Fig 2, I2, III1).
An IVS1–23 C→T mutation was also found in the proband, his
relatives (I1, II1, and III1) without the IVS1–1 G→C mutation, and
two other unrelated erythropoietic protoporphyria patients (data not
shown). This mutation was reported previously as a possible cause of
Is Human Papillomavirus Type 5 the Putative Autoantigen
Involved in Psoriasis?
To the Editor:
While it iswell recognized that psoriasis is aTcell-mediated inflammatory
disease that results in epidermal proliferation (Griffiths and Voorhees,
1996), the identity of the antigen(s) responsible for T cell activation is
still a matter of debate, as recently discussed by Nickoloff and Wrone-
Smith (1998). A strong correlation has been found between acute guttate
psoriasis and streptococcal infections (Baker et al, 1993), and it has been
proposed that some bacterial surperantigens or antigens might activate T
cells (Telfer et al, 1992; Baker et al, 1993; Valdimarsson et al, 1995;
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exon 2 skipping (Nakahashi et al, 1992), but later refuted (Wang et al,
1994) when it was found in all erythropoietic protoporphyria patients
and in some controls, suggesting that it may play some role in the
pathogenesis of erythropoietic protoporphyria.
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Boehncke, 1996; Norris et al, 1997). It was also hypothesized that super-
antigen-activated T cells might induce abnormal expression of keratin
variants that show close homology with streptococcal M protein, and
might stimulate M protein-specific autoreactive T cells (Valdimarsson et
al, 1995). It should be stressed, however, that although T cells specific
for M protein have been detected in patients with psoriasis, they have as
yet not been shown to cross-react with any skin components.
Based on the model of human skin grafted onto SCID mice, it was
recently postulated that there are two steps in the autoimmune pathways
to psoriasis (Nickoloff and Wrone-Smith, 1998). The first step is consid-
ered to be a polyclonal activation of Vβ restricted CD41 T cell subsets
by some bacterial superantigens (Boehncke et al, 1996; Wrone-Smith
and Nickoloff, 1996). These activated T cells, injected intradermally
into the grafted uninvolved psoriatic skin, induced histologic changes
